Bayer to Focus Entirely on Life Science Businesses
LEVERKUSEN, Germany - Bayer announced on September 18 that it plans to focus entirely on the Life Science businesses - HealthCare and CropScience - and float MaterialScience on the stock market as a separate company, positioning Bayer as a leading company in the field of human, animal and plant health.
"Our intention is to create two top global corporations: Bayer as a world-class innovation company in the Life Science businesses and MaterialScience as a leading player in polymers," said Bayer CEO Dr. Marijn Dekkers. He said both companies have excellent prospects for success in their respective industries. Employment levels are expected to remain stable over the next few years, both globally and in Germany.